Hypersensitivity of aquaporin 4-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine and astrocytic modulation

Neurobiology of Aging

Volumn 29, Issue 8, 2008, Pages 1226-1236

  Fan, Yi ^a   Kong, Hui ^a   Shi, Xueru ^a   Sun, Xiulan ^a   Ding, Jianhua ^a   Wu, Jie ^b   Hu, Gang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Aquaporin 4; Astrocyte; Neurodegeneration; Neuroprotection; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AQUAPORIN 4; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTATHIONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; LOCOMOTION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; AQUAPORIN 4; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOSIS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEUROTOXINS; PARKINSONIAN DISORDERS;

EID: 44949151157     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.02.015     Document Type: Article

References (55)

1. Airaksinen M.S., and Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 3 (2002) 383-394
2. Airavaara M., Planken A., Gaddnas H., Piepponen T.P., Saarma M., and Ahtee L. Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice. Eur. J. Neurosci. 20 (2004) 2336-2344
3. Asai S., Iribe Y., Kohno T., and Ishikawa K. Real time monitoring of biphasic glutamate release using dialysis electrode in rat acute brain ischemia. Neuroreport 7 (1996) 1092-1096
4. Ben-Shachar D., Zuk R., and Glinka Y. Dopamine neurotoxicity: inhibition of mitochondrial respiration. J. Neurochem. 64 (1995) 718-723
5. Binder D.K., Oshio K., Ma T., Verkman A.S., and Manley G.T. Increased seizure threshold in mice lacking aquaporin-4 water channels. Neuroreport 15 (2004) 259-262
6. Binder D.K., Yao X., Zador Z., Sick T.J., Verkman A.S., and Manley G.T. Increased seizure duration and slowed potassium kinetics in mice lacking aquaporin-4 water channels. Glia 53 (2006) 631-636
7. Burke R.E., Antonelli M., and Sulzer D. Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture. J. Neurochem. 71 (1998) 517-525
8. Carey J.R., Deskin K.A., Josephson K.T., and Wichmann R.L. Sex differences in tracking performance in patients with Parkinson's disease. Arch. Phys. Med. Rehabil. 83 (2002) 972-977
9. Chen L.W., Yung K.L., and Chan Y.S. Reactive astrocytes as potential manipulation targets in novel cell replacement therapy of Parkinson's disease. Curr. Drug Targets 6 (2005) 821-833
10. Dolman D., Drndarski S., Abbott N.J., and Rattray M.J. Induction of aquaporin 1 but not aquaporin 4 messenger RNA in rat primary brain microvessel endothelial cells in culture. Neurochemistry 93 (2005) 825-833
11. Dringen R., Pfeiffer B., and Hamprecht B. Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J. Neurosci. 19 (1999) 562-569
12. Drukarch B., Schepens E., Stoof J.C., Langeveld C.H., and Van Muiswinkel F.L. Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species. Free Radic. Biol. Med. 25 (1998) 217-220
13. Eberhardt O., Coelln R.V., Kugler S., Lindenau J., Rathke-Hartlieb S., Gerhardt E., Haid S., Isenmann S., Gravel C., Srinivasan A., Bahr M., Weller M., Dichgans J., and Schulz J.B. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J. Neurosci. 20 (2000) 9126-9134
14. Fahn S. Adverse effects of levodopa in Parkinson's disease. In: Calne D.B. (Ed). Handbook of Experimental Pharmacology (1989), Springer-Verlag, Berlin 386-409
15. Fahn S., Przedborski S., and Parkinsonism. In: Rowland L.R. (Ed). Merritt's Neurology. 10th ed. (2000), Lippincott Williams & Wilkins, New York 679-693
16. Fan Y., Zhang J., Sun X.L., Gao L., Zeng X.N., Ding J.H., and Hu G. Sex- and region-specific alterations of basal amino acid and monoamine metabolism in the brain of aquaporin-4 knockout mice. J. Neurosci. Res. 82 (2005) 458-464
17. Fernagut P.O., Diguet E., Bioulac B., and Tison F. MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degeneration. Exp. Neurol. 185 (2004) 47-62
18. Forno L.S., DeLanney L.E., Irwin I., Di Monte D., and Langston J.W. Astrocytes and Parkinson's disease. Prog. Brain Res. 94 (1992) 429-436
19. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P.A., Collins F., Hoffer B.J., and Gerhardt G.A. Functional recovery in Parkinsonian monkeys treated with GDNF. Nature 380 (1996) 252-255
20. Giovanni A., Sieber B.A., Heikkila R.E., and Sonsalla P.K. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice. J. Pharmacol. Exp. Ther. 257 (1991) 691-697
21. Grundl W., Ziegler R., Westphal K.P., Hufnagl M., Szirtes J., and Kornhuber H.H. Parkinson's syndrome: cranial computed-tomography findings. Their dependence on sex and age. Acta Med. Hung. 48 (1991) 127-136
22. Hatakeyama S., Hayasaki Y., Masuda M., Kazusaka A., and Fujita S. Mechanism for mouse strain differences in the protective effect of Sudan III against the in vivo genotoxicity of 7,12-dimethylbenz[a]anthracene. Toxicol. Lett. 89 (1996) 231-239
23. Ho A., Gore A.C., Weickert C.S., and Blum M. Glutamate regulation of GDNF gene expression in the striatum and primary striatal astrocytes. Neuroreport 6 (1995) 1454-1458
24. Humpel C., Hoffer B., Stromberg I., Bektesh S., Collins F., and Olson L. Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation. Neuroscience 59 (1994) 791-795
25. Hunot S., Bernard V., Faucheux B., Boissiere F., Leguern E., Brana C., Gautris P.P., Guerin J., Bloch B., Agid Y., and Hirsch E.C. Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson's disease. J. Neural Transm. 103 (1996) 1043-1052
26. Inoue T., Tsui J., Wong N., Wong S.Y., Suzuki F., and Kwok Y.N. Expression of glial cell line-derived neurotrophic factor and its mRNA in the nigrostriatal pathway following MPTP treatment. Brain Res. 826 (1999) 306-308
27. Kordower J.H., Emborg M.E., Bloch J., Ma S.Y., Chu Y., Leventhal L., McBride J., Chen E.Y., Palfi S., Roitberg B.Z., Brown W.D., Holden J.E., Pyzalski R., Taylor M.D., Carvey P., Ling Z., Trono D., Hantraye P., Deglon N., and Aebischer P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290 (2000) 767-773
28. Liberatore G.T., Jackson-Lewis V., Vukosavic S., Mandir A.S., Vila M., McAuliffe W.G., Dawson V.L., Dawson T.M., and Przedborski S. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 5 (1999) 1403-1409
29. Mandir A.S., Przedborski S., Jackson-Lewis V., Wang Z.Q., Simbulan-Rosenthal C.M., Smulson M.E., Hoffman B.E., Guastella D.B., Dawson V.L., and Dawson T.M. Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism. Proc. Natl. Acad. Sci. USA 96 (1999) 5774-5779
30. Manley G.T., Binder D.K., Papadopoulos M.C., and Verkman A.S. New insights into water transport and edema in the central nervous system from phenotype analysis of aquaporin-4 null mice. Neuroscience 129 (2004) 983-991
31. Maragakis N.J., and Rothstein J.D. Mechanisms of disease: astrocytes in neurodegenerative disease. Nat. Clin. Pract. Neurol. 12 (2006) 679-689
32. Mena M.A., de Bernardo S., Casarejos M.J., Canals S., and Rodriguez-Martin E. The role of astroglia on the survival of dopamine neurons. Mol. Neurobiol. 25 (2002) 245-263
33. Mudo G., Persson H., Timmusk T., Funakoshi H., Bindoni M., and Belluardo N. Increased expression of trkB and trkC messenger RNAs in the rat forebrain after focal mechanical injury. Neuroscience 57 (1993) 901-912
34. Muthane U., Ramsay K.A., Jiang H., Jackson-Lewis V., Donaldson D., Fernando S., Ferreira M., and Przedborski S. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice. Exp. Neurol. 126 (1994) 195-204
35. Nakajima K., Hida H., Shimano Y., Fujimoto I., Hashitani T., Kumazaki M., Sakurai T., and Nishino H. GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons. Brain Res. 916 (2001) 76-84
36. Nielsen S., Nagelhus E.A., Amiry-Moghaddam M., Bourque C., Agre P., and Ottersen O.P. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J. Neurosci. 17 (1997) 171-180
37. +-sensing fluorescent indicator. Nat. Methods 2 (2005) 825-827
38. Pakkenberg B., Moller A., Gundersen H.J., Mouritzen Dam A., and Pakkenberg H. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. J. Neurol. Neurosurg. Psych. 54 (1991) 30-33
39. Przedborski S., Jackson-Lewis V., Naini A.B., Jakowec M., Petzinger G., Miller R., and Akram M. The Parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J. Neurochem. 76 (2001) 1265-1274
40. +. Neurosci. Lett. 75 (1987) 323-328
41. Saadoun S., Papadopoulos M.C., Watanabe H., Yan D., Manley G.T., and Verkman A.S. Involvement of aquaporin-4 in astroglial cell migration and glial scar formation. J. Cell Sci. 118 (2005) 5691-5698
42. Schmidt-Kastner R., Tomac A., Hoffer B., Bektesh S., Rosenzweig B., and Olson L. Glial cell-line derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats. Brain Res. Mol. Brain Res. 26 (1994) 325-330
43. Seifert G., Schilling K., and Steinhauser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat. Rev. Neurosci. 7 (2006) 194-206
44. Smeyne M., Jiao Y., Shepherd K.R., and Smeyne R.J. Glia cell number modulates sensitivity to MPTP in mice. Glia 52 (2005) 144-152
45. Sofroniew M.V. Reactive astrocytes in neural repair and protection. Neuroscientist 11 (2005) 400-407
46. Stromberg I., Bjorklund L., Johansson M., Tomac A., Collins F., Olson L., Hoffer B., and Humpel C. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124 (1993) 401-412
47. Teismann P., Tieu K., Cohen O., Choi D.K., Wu du C., Marks D., Vila M., Jackson-Lewis V., and Przedborski S. Pathogenic role of glial cells in Parkinson's disease. Mov. Disord. 18 (2003) 121-129
48. Teismann P., and Schulz J.B. Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation. Cell Tissue Res. 318 (2004) 149-161
49. Tokumine J., Sugahara K., Kakinohana O., and Marsala M. The spinal GDNF level is increased after transient spinal cord ischemia in the rat. Acta Neurochir. Suppl. 86 (2003) 231-234
50. Volterra A., and Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 6 (2005) 626-640
51. Wang S., Hu L.F., Yang Y., Ding J.H., and Hu G. Studies of ATP-sensitive potassium channels on 6-hydroxydopamine and haloperidol rat models of Parkinson's disease: implications for treating Parkinson's disease?. Neuropharmacology 48 (2005) 984-992
52. Wang X.F., and Cynader M.S. Astrocytes provide cysteine to neurons by releasing glutathione. J. Neurochem. 74 (2000) 1434-1442
53. Wen H., Nagelhus E.A., Amiry-Moghaddam M., Agre P., Ottersen O.P., and Nielsen S. Ontogeny of water transport in rat brain: postnatal expression of the aquaporin-4 water channel. Eur. J. Neurosci. 11 (1999) 935-945
54. West M.J. New stereological methods for counting neurons. Neurobiol. Aging 14 (1993) 275-285
55. Wu du C., Tieu K., Cohen O., Choi D.K., Vila M., Jackson-Lewis V., Teismann P., and Przedborski S. Glial cell response: a pathogenic factor in Parkinson's disease. J. Neurovirol. 8 (2002) 551-558